| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |